ESH 2004 Paris1 Blood Pressure Control by Home Monitoring A Meta-Analysis of Randomised Trials FP Cappuccio, SM Kerry, L Forbes, A Donald Published in:

Slides:



Advertisements
Similar presentations
Telephone based self-management support for vascular conditions via non-healthcare professionals: a systematic review and meta-analysis Dr Nicola Small,
Advertisements

Introducing... Reproduced and modified from a presentation produced by Zoë Debenham from the original presentation created by Kate Light, Cochrane Trainer.
JNC 8 Guidelines….
Blood pressure reduction with statins Meta-analysis of randomised controlled trials P. Strazzullo 1, S.M. Kerry 2, A. Barbato 1,2, M. Versiero 1, L. D’Elia.
QUASI-EXPERIMENTAL STUDY DESIGNS IN EVALUATING MEDICINES USE INTERVENTIONS 1 Lloyd Matowe 2 Craig Ramsay 1 Faculty of Pharmacy, Kuwait University 2 HSRU,
Update on hypertension - diagnosis, monitoring and guideline treatment targets Prof. Richard McManus, Birmingham, United Kingdom.
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
PROGNOSTIC SIGNIFICANCE OF PRIMARY TUMORAL FDG UPTAKE MEASURED BY PET: Systematic Review and Meta-analysis Ben A. Dwamena, MD.
Modelling the impact of service innovation in Stroke Care Tanaka Business School: Imperial College. Lead researcher: Dr Benita Cox Background Stroke is.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Long-term predictive value of assessment of coronary atherosclerosis by contrast- enhanced coronary computed tomography angiography: meta- analysis and.
Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review Journal club presentation
Enhanced recovery meta-analysis Kirsty Cattle Research Registrar.
CVD Prevention in Primary Care CVD Guidelines Symposium Wednesday 3 rd Novemeber 2010 Dr John Cox FRCPI FRCGP.
Critical appraisal Systematic Review กิตติพันธุ์ ฤกษ์เกษม ภาควิชาศัลยศาสตร์ มหาวิทยาลัยเชียงใหม่
William B. Kannel, MD, FACC Former Director, Framingham Heart Study
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
Antiplatelet or Anticoagulant: Do They Have the same Efficacy? University of Central Florida Deborah Andrews RN, BSN.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
European Society of Cardiology Cardiovascular diseases in women.
Effects of Pediatric Asthma Education on Hospitalizations and Emergency Department Visits: A Meta-Analysis June 3, 2007 Janet M. Coffman, PhD, Michael.
Systematic Reviews.
How to Analyze Systematic Reviews: practical session Akbar Soltani.MD. Tehran University of Medical Sciences (TUMS) Shariati Hospital
Evidence Based Medicine Meta-analysis and systematic reviews Ross Lawrenson.
A Systematic Review On The Hazards Of Aspirin Discontinuation Among Patients With Or At Risk For Coronary Artery Disease Giuseppe Biondi Zoccai Hemodynamics.
The TRial Of Preventing HYpertension (TROPHY) TROPHY.
Hypertension: Blood Pressure Measurement and the new NICE guideline Prof Richard McManus BHS Annual Meeting Cambridge 2011 NICE clinical guideline 127.
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
A systematic meta-analysis of randomized controlled trials for adjuvant chemotherapy for localized resectable soft-tissue sarcoma Nabeel Pervaiz Nigel.
Should developing countries continue to use older drugs for essential hypertension? A prescription survey in South Africa suggested that prescribers were.
EBC course 10 April 2003 Critical Appraisal of the Clinical Literature: The Big Picture Cynthia R. Long, PhD Associate Professor Palmer Center for Chiropractic.
Systematic Reviews By Jonathan Tsun & Ilona Blee.
Clinical Writing for Interventional Cardiologists.
Association between Systolic Blood Pressure and Congestive Heart Failure Complication among Hypertensive and Diabetic Hypertensive Patients Mrs. Sutheera.
Evidence-Based Medicine: What does it really mean? Sports Medicine Rounds November 7, 2007.
HvC Comparative Effectiveness Project Groups 5 and 6
Pharmacist-Physician Collaborative Medication Therapy Management Services (MTMS) PI: Jan Hirsch, RPh, PhD Carol M. Mangione, MD, MSPH Barbara A. Levey.
2nd Concertation Meeting Brussels, September 8, 2011 Reinhard Prior, Scientific Coordinator, HIM Evidence in telemedicine: a literature review.
Objectives  Identify the key elements of a good randomised controlled study  To clarify the process of meta analysis and developing a systematic review.
Methodological quality of malaria RCTs conducted in Africa Vittoria Lutje*^, Annette Gerritsen**, Nandi Siegfried***. *Cochrane Infectious Diseases Group.
1 Lecture 10: Meta-analysis of intervention studies Introduction to meta-analysis Selection of studies Abstraction of information Quality scores Methods.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2012.
Course: Research in Biomedicine and Health III Seminar 5: Critical assessment of evidence.
To establish whether a difference in SBP between arms is associated with peripheral or cardiovascular (CV) disease, and with an increased risk of CV or.
Systematic reviews and meta-analyses: when and how to do them Andrew Smith Royal Lancaster Infirmary 18 May 2015.
Evidence Based Practice (EBP) Riphah College of Rehabilitation Sciences(RCRS) Riphah International University Islamabad.
Short Sleep Duration as a Predictor of Cardiovascular Events Summary and Comment by Jamaluddin Moloo, MD, MPH Published in Journal Watch General Medicine.
Flow Diagram of Identification of Randomized Trials for Inclusion Goran Bjelakovic, et al. JAMA. 2007;297:
1 Lecture 10: Meta-analysis of intervention studies Introduction to meta-analysis Selection of studies Abstraction of information Quality scores Methods.
Improving risk factor management for patients with poorly controlled type 2 diabetes: a systematic review of non-pharmaceutical interventions in primary.
Women’s Health Academic Centre CRADLE Community Blood Pressure Monitoring in Rural Africa: cfaDetection of Underlying Pre-eclampsia Hezelgrave N, Irvine.
A SYSTEMATIC REVIEW OF THE PREVENTIVE EFFECT OF ORAL HYGIENE ON PNEUMONIA AND RESPIRATORY TRACT INFECTION IN ELDERLY PEOPLE IN HOSPITALS AND NURSING HOMES:
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
Do Short-Term Medical Trips Make a Difference in Treating NCDs? Mark Ryan, MD Goldie Chang, P3; Camille Hochheimer, PhD student; Marwah Khalid, MD; Dien.
Nephrology Journal Club The SPRINT Trial Parker Gregg
Systematic review of Present clinical reality
From ESH 2016 | POS 4C: A. Power, MD
Hypertension November 2016
From ESH 2016 | POS 3C: Chiara Lorenzi, MD
Prognostic factors for musculoskeletal injury identified through medical screening and training load monitoring in professional football (soccer): a systematic.
Teaching Tool: Blood Pressure Classification
Systolic Blood Pressure Intervention Trial (SPRINT)
Geir Smedslund, Ph.D.: Diakonhjemmet Hospital (DH)
End point Net change with soy supplements vs control (95% CI) p
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Doctors record higher blood pressures than nurses: systematic review and meta-analysis by Christopher E Clark, Isabella A Horvath, Rod S Taylor, and John.
pulmonary embolism protocol -- EMB review
Hypertension November 2016
Does cinnamon reduce fasting blood glucose in Type II diabetics?
Presentation transcript:

ESH 2004 Paris1 Blood Pressure Control by Home Monitoring A Meta-Analysis of Randomised Trials FP Cappuccio, SM Kerry, L Forbes, A Donald Published in: Br Med J 2004; 329:

ESH 2004 Paris2 Background  High blood pressure is the most preventable cause of death and disability due to CVD

ESH 2004 Paris3 Background  High blood pressure is the most preventable cause of death and disability due to CVD  Blood pressure is usually measured and monitored in the healthcare system by health professionals (doctors, nurses, pharmacists)

ESH 2004 Paris4 Background  High blood pressure is the most preventable cause of death and disability due to CVD  Blood pressure is usually measured and monitored in the healthcare system by health professionals (doctors, nurses, pharmacists)  With the introduction and validation of new electronic devices, self blood pressure monitoring at home is becoming increasingly popular

ESH 2004 Paris5 Background  High blood pressure is the most preventable cause of death and disability due to CVD  Blood pressure is usually measured and monitored in the healthcare system by health professionals (doctors, nurses, pharmacists)  With the introduction and validation of new electronic devices, self blood pressure monitoring at home is becoming increasingly popular  However, there is little evidence as to whether using home monitoring is associated with a better control of high blood pressure

ESH 2004 Paris6 Objective  To compare blood pressure levels and proportion on target in people with essential hypertension undergoing home blood pressure monitoring

ESH 2004 Paris7 Design and Methods  Meta-analysis of randomised controlled trials comparing ‘home’ or ‘self’ blood pressure monitoring vs ‘usual’ blood pressure monitoring in the healthcare system

ESH 2004 Paris8 Design and Methods  Meta-analysis of randomised controlled trials comparing ‘home’ or ‘self’ blood pressure monitoring vs ‘usual’ blood pressure monitoring in the healthcare system  Medline (1966 to Jan 2003), Embase (1980 to Jan 2003), Databases (Cochrane, Clinical Effectiveness, HTA, NHS Economic Evaluation, TRIP, CRD, AHRQ) identified 253 potential trials

ESH 2004 Paris9 Flow Diagram RCTs identified (n=253) RCTs retrieved (n=21) RCTs suitable (n=21) RCTs included (n=18) Not meeting inclusion criteria (n=232) Not using BP as outcome (n=3) Systolic (n=13)Diastolic (n=16) Mean (n=3) Targets (n=6)

ESH 2004 Paris10 Design and Methods  Meta-analysis of randomised controlled trials comparing ‘home’ or ‘self’ blood pressure monitoring vs ‘usual’ blood pressure monitoring in the healthcare system  Medline (1966 to Jan 2003), Embase (1980 to Jan 2003), Databases (Cochrane, Clinical Effectiveness, HTA, NHS Economic Evaluation, TRIP, CRD, AHRQ) identified 253 potential trials 1359 patients allocated to home blood pressure monitoring and 1355 to ‘control’ groups

ESH 2004 Paris11 Statistical Analysis  Random effects model

ESH 2004 Paris12 Statistical Analysis  Random effects model  Difference in BP (95% CI)  Relative risk (95% CI)

ESH 2004 Paris13 Statistical Analysis  Random effects model  Difference in BP (95% CI)  Relative risk (95% CI)  Publication bias by funnel plot and Egger’s test  ‘Trim and fill’ method  Heterogeneity by chi-square

ESH 2004 Paris14 RESULTS 1. Systolic blood pressure achieved in people monitoring blood pressure at home compared with people whose blood pressure was monitored by health professionals in clinical settings Heterogeneity p<0.001

ESH 2004 Paris15 RESULTS 2. Diastolic blood pressure achieved in people monitoring blood pressure at home compared with people whose blood pressure was monitored by health professionals in clinical settings Heterogeneity p=0.014

ESH 2004 Paris16 RESULTS 3. Mean blood pressure achieved in people monitoring blood pressure at home compared with people whose blood pressure was monitored by health professionals in clinical settings Heterogeneity p=0.319

ESH 2004 Paris17 RESULTS 4. Funnel plot for systolic blood pressure

ESH 2004 Paris18 RESULTS 5. Egger’s test for publication bias and revised estimates by ‘trim and fill’ test Egger’s test (p) ‘Trim & Fill’ estimate 95% C.I. SBP (mmHg) to 5.3 DBP (mmHg) to 3.2

ESH 2004 Paris19 RESULTS 6. Standardised relative risk of blood pressure above target in people monitoring blood pressure at home compared with people whose blood pressure was monitored by health professionals in clinical settings

ESH 2004 Paris20 Studies published in 2004 oStaessen JA et al. JAMA 2004;291: RCT of 400 participants up to 1 year (Clinic vs Home BP). Home BP lower than Clinic BP.

ESH 2004 Paris21 oStaessen JA et al. JAMA 2004;291: RCT of 400 participants up to 1 year (Clinic vs Home BP). Home BP lower than Clinic BP. oBobrie G et al. JAMA 2004;291: Prospective study of <5,000 treated elderly hypertensives followed for 3.2 years. Home BP better prognostic values for CVD events than Clinic BP. Studies published in 2004

ESH 2004 Paris22 oStaessen JA et al. JAMA 2004;291: RCT of 400 participants up to 1 year (Clinic vs Home BP). Home BP lower than Clinic BP. oBobrie G et al. JAMA 2004;291: Prospective study of <5,000 treated elderly hypertensives followed for 3.2 years. Home BP better prognostic values for CVD events than Clinic BP. oCuspidi C et al. J Hum Hypert 2004; online 22 April Cross-sectional study of 1350 hypertensives; 66% practising Home BP monitoring. Higher rate of Clinic BP control amongst them. Studies published in 2004

ESH 2004 Paris23 Summary and Conclusions  Patients who monitor their blood pressure ‘at home’ have a lower ‘clinic’ blood pressure compared to those whose blood pressure is monitored in the healthcare system

ESH 2004 Paris24 Summary and Conclusions  Patients who monitor their blood pressure ‘at home’ have a lower ‘clinic’ blood pressure compared to those whose blood pressure is monitored in the healthcare system  A greater proportion of them also achieve blood pressure targets when assessed ‘in the clinic’

ESH 2004 Paris25 Summary and Conclusions  Patients who monitor their blood pressure ‘at home’ have a lower ‘clinic’ blood pressure compared to those whose blood pressure is monitored in the healthcare system  A greater proportion of them also achieve blood pressure targets when assessed ‘in the clinic’  The reasons for this are not clear. However, greater direct involvement of the patient in his/her own care might be beneficial through greater awareness, motivation, concordance etc

ESH 2004 Paris26 Summary and Conclusions  Patients who monitor their blood pressure ‘at home’ have a lower ‘clinic’ blood pressure compared to those whose blood pressure is monitored in the healthcare system  A greater proportion of them also achieve blood pressure targets when assessed ‘in the clinic’  The reasons for this are not clear. However, greater direct involvement of the patient in his/her own care might be beneficial through greater awareness, motivation, concordance etc  Home blood pressure measurement can be used as an adjunctive practice to help patients manage their hypertension more effectively